Correspondence 0001104659-23-117339 from PaxMedica, Inc. (PXMD) (CIK 0001811623)

PaxMedica, Inc. (PXMD) (CIK 0001811623)
Date: Nov. 13, 2023 · CIK: 0001811623 · Accession: 0001104659-23-117339

View on Edgar

AI Filing Summary & Sentiment

File numbers found in text: 333-275416

Date

November 13, 2023

Author

/s/ Howard Weisman

Form

CORRESP

Company

PaxMedica, Inc. (PXMD) (CIK 0001811623)

Letter

November 13, 2023

VIA EDGAR

Office of Life Sciences

Division of Corporation Finance

United States Securities and Exchange Commission

100 F Street, N.E.

Washington, D.C. 20549

Attention: Doris Stacey Gama

Re:

PaxMedica, Inc.

Withdrawal of Request for Acceleration of Registration Statement on Form S-1

File No. 333-275416

Dear. Ms. Gamma,

PaxMedica, Inc. (the “Company”) hereby withdraws its request, dated November 9, 2023, that the Registration Statement on Form S-1 (File No. 333-275416) (the “Registration Statement”) become effective on Monday, November 13, 2023, at 5:15 p.m. Eastern Time, or as soon thereafter as practicable. The Company is no longer requesting that the Registration Statement be declared effective at this time and we hereby formally withdraw our request for acceleration of the effective date.

If you have any questions regarding the foregoing, please contact our counsel, Anna Tomczyk of Dechert LLP at (212) 641-5626.

Sincerely,
PAXMEDICA, INC.

Show Raw Text

CORRESP
1
filename1.htm

November 13, 2023

VIA EDGAR

Office of Life Sciences

Division of Corporation Finance

United States Securities and Exchange Commission

100 F Street, N.E.

Washington, D.C. 20549

Attention:
  Doris Stacey Gama

    Re:

    PaxMedica, Inc.

    Withdrawal of Request for Acceleration of Registration Statement
    on Form S-1

    File No. 333-275416

Dear. Ms. Gamma,

PaxMedica, Inc. (the “Company”)
hereby withdraws its request, dated November 9, 2023, that the Registration Statement on Form S-1 (File No. 333-275416) (the “Registration
Statement”) become effective on Monday, November 13, 2023, at 5:15 p.m. Eastern Time, or as soon thereafter as practicable.
The Company is no longer requesting that the Registration Statement be declared effective at this time and we hereby formally withdraw
our request for acceleration of the effective date.

If you have any questions regarding the foregoing,
please contact our counsel, Anna Tomczyk of Dechert LLP at (212) 641-5626.

    Sincerely,

    PAXMEDICA, INC.

    /s/ Howard Weisman

    Howard Weisman

    Chief Executive Officer

 cc: Anna Tomczyk, Dechert LLP

SecProbe.io